Mycobacterium mucogenicum: Report of a skin infection associated with etanercept

Dermatology Online Journal

Volumn 14, Issue 1, 2008, Pages

  Shehan, James M ^a   Sarma, Deba P ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; ETANERCEPT; MINOCYCLINE; PREDNISONE; ANTIINFECTIVE AGENT; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LOW DRUG DOSE; MYCOBACTERIUM; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SKIN INFECTION; BACTERIAL SKIN DISEASE; DRUG ANTAGONISM; MIDDLE AGED; MYCOBACTERIOSIS; OPPORTUNISTIC INFECTION;

ANTI-BACTERIAL AGENTS; ARTHRITIS, RHEUMATOID; CLARITHROMYCIN; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; MINOCYCLINE; MYCOBACTERIUM INFECTIONS; OPPORTUNISTIC INFECTIONS; RECEPTORS, TUMOR NECROSIS FACTOR; SKIN DISEASES, BACTERIAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38749122398     PISSN: None     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Mufti AH, Toye BW, McKendry RR, Angel JB. Mycobacterium abscessus infection after use of tumor necrosis factor α inhibitor therapy: case report and review of infectious complications associated with tumor necrosis factor α inhibitor use. Diagn Microbiol Infect Dis. 2005 Nov;53 (3):233-8.
2. Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis. 2004 May 1; 38(9):1261-5.
3. Saliu OY, Sofer C, Stein DS, Schwander SK, Wallis RS. Tumor-necrosisfactor blockers: differential effects on mycobacterial immunity. J Infect Dis. 2006 Aug 15;194(4):486-92.
4. Shen C, Assche GV, Colpaert S, Maerten P, Geboes K, Rutgeerts P, Ceuppens JL. Adalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept. Aliment Pharmacol Ther. 2005 Feb1;21(3):251-8.
5. Adekambi T, Foucalt C, La Scola B, Drancourt M. Report of two fatal cases of Mycobacterium mucogenicum central nervous system infection in immunocompetent patients. J Clin Microbiol. 2006 Mar;44(3):837-840.
6. Covert TC, Rodgers MR, Reyes AL, Stelma GN Jr. Occurrence of nontuberculous mycobacteria in environmental samples. Appl Environ Microbiol. 1999 Jun; 65(6):2492-6.
7. Fonteyn N, Wauters G, Vandercam B, Degraux J, Avesani V, Vincent V, et al. Mycobacterium mucogenicum sepsis in an immunocompetent patient. J Infect. 2006 Sep;53(3):143-6.
8. Springer B, Bottger EC, Kirschner P, Wallace RJ Jr. Phylogeny of the Mycobacterium chelonae-like organism based on partial sequencing of the 16S rRNA gene and proposal of Mycobacterium mucogenicum sp. nov. Int J Syst Bacteriol. 1995 Apr;45(2):262-7.
9. Han XY, De I, Jacobson KL. Rapidly growing mycobacteria: clinical and microbiologic studies of 115 cases. Am J Clin Path. 2007 Oct;128(4):612-21.
10. Kline S, Cameron S, Streifel A, Yakrus MA, Kairis F, Peacock K, Besser J, Cooksey RC. An outbreak of bacteremias associated with Mycobacterium mucogenicum in a hospital water supply. Infect Control Hosp Epidemiol. 2004 Dec; 25(12):1042-9.
11. Goldblatt MR, Ribes JA. Mycobacterium mucogenicum isolated from a patient with granulomatous hepatitis. Arch Pathol Lab Med. 2002 Jan;126 (1):73-5.
12. Vargas J, Gamboa C, Negrin D, Correa M, Sandoval C, Aguiar A, Prieto M, Rodriguez-Morales AJ, De Waard J, Yakrus M. Disseminated Mycobacterium mucogenicum infection in a patient with idiopathic CD4+ T lymphocytopenia manifesting as fever of unknown origin. Clin Infect Dis. 2005 Sep 1;41(5):759-60.
13. Paterson DL, Singh N, Gayowski T, Marino I. Mycobacterium mucogenicum bacteremia in a patient with cirrhosis. J of Clin Gastro. 1998 Dec;27(4):346-7.